1. Home
  2. LOB vs AVLN Comparison

LOB vs AVLN Comparison

Compare LOB & AVLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Live Oak Bancshares Inc.

LOB

Live Oak Bancshares Inc.

N/A

Current Price

$31.91

Market Cap

1.6B

Sector

Finance

ML Signal

N/A

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$28.64

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LOB
AVLN
Founded
2008
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2014
2026

Fundamental Metrics

Financial Performance
Metric
LOB
AVLN
Price
$31.91
$28.64
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$40.50
★ $61.00
AVG Volume (30 Days)
262.1K
★ 469.5K
Earning Date
10-21-2026
11-12-2026
Dividend Yield
★ 0.37%
N/A
EPS Growth
★ 31.95
N/A
EPS
★ 1.86
N/A
Revenue
N/A
N/A
Revenue This Year
$12.75
N/A
Revenue Next Year
$13.70
N/A
P/E Ratio
$17.59
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.18
$22.24
52 Week High
$44.53
$40.17

Technical Indicators

Market Signals
Indicator
LOB
AVLN
Relative Strength Index (RSI) 29.22 51.71
Support Level $31.44 $25.86
Resistance Level $38.49 $29.48
Average True Range (ATR) 1.14 2.07
MACD -0.15 0.04
Stochastic Oscillator 0.21 48.25

Price Performance

Historical Comparison
LOB
AVLN

About LOB Live Oak Bancshares Inc.

Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

Share on Social Networks: